These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10874529)

  • 1. New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease.
    Graves PN; Davies TF
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):267-86, vi. PubMed ID: 10874529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
    Endo T; Kobayashi T
    J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
    Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
    J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.
    Chen CR; Pichurin P; Nagayama Y; Latrofa F; Rapoport B; McLachlan SM
    J Clin Invest; 2003 Jun; 111(12):1897-904. PubMed ID: 12813025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
    Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization.
    Pichurin PN; Chen CR; Chazenbalk GD; Aliesky H; Pham N; Rapoport B; McLachlan SM
    J Immunol; 2006 Jan; 176(1):668-76. PubMed ID: 16365463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the autoreactivity against thyroid stimulating hormone receptor.
    Kohn LD; Kosugi S; Ban T; Saji M; Ikuyama S; Giuliani C; Hidaka A; Shimura H; Akamizu T; Tahara K
    Int Rev Immunol; 1992; 9(2):135-65. PubMed ID: 1283175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into Graves' hyperthyroidism from animal models.
    McLachlan SM; Nagayama Y; Rapoport B
    Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
    Bahn RS
    Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.